Literature DB >> 19294769

Correlation of p53 over-expression and alteration in p53 gene detected by polymerase chain reaction-single strand conformation polymorphism in adenocarcinoma of gastric cancer patients from India.

Sajjad Karim1, Arif Ali.   

Abstract

AIM: To study the alterations in p53 gene among Indian gastric cancer patients and to correlate them with the various clinicopathological parameters.
METHODS: A total of 103 gastric cancer patients were included in this study. The p53 alterations were studied by both immunohistochemical method as well as polymerase chain reaction (PCR)-single strand conformation polymorphism (SSCP) analysis. We only studied four (exon 5, 6, 7, and 8) of the 11 p53 exons. The alterations in p53 were also correlated with respect to various clinicopathological parameters.
RESULTS: Among 103 cases, p53 over-expression and alteration were detected in 37 (35.92%) and 19 (18.44%) cases, respectively. Most of the p53 alterations were found at exon 5 (31.54%), followed by exon 6 (26.31%), exon 7 (21.04%) and exon 8 (21.04%). A significant correlation of p53 over-expression was found with p53 alteration (P = 0.000). Concordance between p53 alteration (as detected by SSCP) and over-expression [as detected by immunohistochemistry (IHC)] was found in 75% cases. We found that IHC-positive/SSCP-negative cases accounted for 21% of cases and IHC-negative/SSCP-positive cases accounted for remaining 4% cases.
CONCLUSION: Our results show that p53 gene mutations are significantly correlated with p53 protein over-expression, with 75% concordance in over-expression and alteration in the p53 gene, but 25% disconcordance also cautions against the assumption that p53 over-expression is always associated with a gene mutation. There may be other mechanisms responsible for stabilization and accumulation of p53 protein with no evidence of gene mutation that reflect an accumulation of a non-mutated protein, or a false negative SSCP result.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19294769      PMCID: PMC2658834          DOI: 10.3748/wjg.15.1381

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  49 in total

1.  P53 in tumour pathology: can we trust immunocytochemistry?

Authors:  D Wynford-Thomas
Journal:  J Pathol       Date:  1992-04       Impact factor: 7.996

Review 2.  Molecular biological observations in gastric cancer.

Authors:  E Tahara; S Semba; H Tahara
Journal:  Semin Oncol       Date:  1996-06       Impact factor: 4.929

3.  Gastric carcinoma at Tikur Anbessa Hospital, Addis Ababa.

Authors:  O Johnson; T Ersumo; A Ali
Journal:  East Afr Med J       Date:  2000-01

4.  Clonal analysis of human colorectal tumors.

Authors:  E R Fearon; S R Hamilton; B Vogelstein
Journal:  Science       Date:  1987-10-09       Impact factor: 47.728

Review 5.  TP53 tumor suppressor gene: a model for investigating human mutagenesis.

Authors:  C Caron de Fromentel; T Soussi
Journal:  Genes Chromosomes Cancer       Date:  1992-01       Impact factor: 5.006

6.  Survival after resection of gastric cancer and prognostic relevance of systematic lymph node dissection: twenty years experience in Taiwan.

Authors:  W J Lee; W C Lee; S J Houng; C T Shun; R L Houng; P H Lee; K J Chang; T C Wei; K M Chen
Journal:  World J Surg       Date:  1995 Sep-Oct       Impact factor: 3.352

7.  Molecular mechanism of stomach carcinogenesis.

Authors:  E Tahara
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

Review 8.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Authors:  M S Greenblatt; W P Bennett; M Hollstein; C C Harris
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

9.  p53 gene mutations inside and outside of exons 5-8: the patterns differ in breast and other cancers.

Authors:  A Hartmann; H Blaszyk; R M McGovern; J J Schroeder; J Cunningham; E M De Vries; J S Kovach; S S Sommer
Journal:  Oncogene       Date:  1995-02-16       Impact factor: 9.867

10.  Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas.

Authors:  B Dix; P Robbins; S Carrello; A House; B Iacopetta
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

View more
  11 in total

1.  Clonality analysis of neuroendocrine cells in gastric adenocarcinoma.

Authors:  Ling-Ling Wang; Gen-You Yao; Zhong-Sheng Zhao; Xiao-Li Wei; Ru-Jun Xu
Journal:  World J Gastroenterol       Date:  2013-08-28       Impact factor: 5.742

2.  Omission of breakfast and risk of gastric cancer in Mexico.

Authors:  Monserrat Verdalet-Olmedo; Clara Luz Sampieri; Jaime Morales-Romero; Hilda Montero-L de Guevara; Alvaro Manuel Machorro-Castaño; Kenneth León-Córdoba
Journal:  World J Gastrointest Oncol       Date:  2012-11-15

3.  Immunohistochemical Expression of Human Epidermal Growth Factor Receptor 2 (HER2) and p53 in Gastric Adenocarcinoma: A Pilot Study from Northern India.

Authors:  Shashikant C U Patne; V B Abhilash; Vinod Kumar Dixit; Richa Katiyar; Sandip Kumar; Gyan Prakash Singh
Journal:  J Clin Diagn Res       Date:  2017-05-01

4.  Genetic mutations of p53 and k-ras in gastric carcinoma patients from Hunan, China.

Authors:  Han-Chun Chen; Hui-Juan Chen; Md Asaduzzaman Khan; Zhou-Zhou Rao; Xin-Xing Wan; Bo Tan; Dian-Zheng Zhang
Journal:  Tumour Biol       Date:  2010-11-16

5.  Correlation of p53 Overexpression with the Clinicopathological Prognostic Factors in Colorectal Adenocarcinoma.

Authors:  Vijaya Mysorekar; Adithi Raj; Smitha Shetty
Journal:  J Clin Diagn Res       Date:  2016-12-01

6.  Immunohistochemical expression of IMP3 and p53 in inflammatory lesions and neoplastic lesions of the gastric mucosa.

Authors:  Johanna D Strehl; Josef Hoegel; Ines Hornicek; Arndt Hartmann; Marc-Oliver Riener
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

7.  Downregulated Expression of E-cadherin and TP53 in Patients with Gastric Diseases: the Involvement of H. pylori Infection and Its Virulence Markers.

Authors:  Mariane Avante Ferraz; Luanna Munhoz Zabaglia; Weendelly Nayara Pereira; Wilson Aparecido Orcini; Roger Willian de Labio; Agostinho Caleman Neto; Fernanda Wisnieski; Danielle Queiroz Calcagno; Leonardo Caires Santos; Paulo Pimentel Assumpção; Rommel Rodriguez Burbano; Ricardo Artigiani; Marilia de Arruda Cardoso Smith; Spencer Luiz Marques Payão; Lucas T Rasmussen
Journal:  J Gastrointest Cancer       Date:  2016-03

8.  Different effects of p53 protein overexpression on the survival of gastric cancer patients according to Lauren histologic classification: a retrospective study.

Authors:  Ki Wook Kim; Nayoung Kim; Yonghoon Choi; Won Seok Kim; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Dong Ho Lee; Young Suk Park; Sang-Hoon Ahn; Do Joong Park; Hyung-Ho Kim; Hye Seung Lee; Ji-Won Kim; Jin Won Kim; Keun-Wook Lee; Won Chang; Ji Hoon Park; Yoon Jin Lee; Kyoung Ho Lee; Young Hoon Kim
Journal:  Gastric Cancer       Date:  2021-02-18       Impact factor: 7.370

9.  High glucose promotes gastric cancer chemoresistance in vivo and in vitro.

Authors:  Wei Zhao; Rui Chen; Mei Zhao; Liang Li; Lin Fan; Xiang-Ming Che
Journal:  Mol Med Rep       Date:  2015-03-20       Impact factor: 2.952

10.  A Novel Electrochemical Microfluidic Chip Combined with Multiple Biomarkers for Early Diagnosis of Gastric Cancer.

Authors:  Yao Xie; Xiao Zhi; Haichuan Su; Kan Wang; Zhen Yan; Nongyue He; Jingpu Zhang; Di Chen; Daxiang Cui
Journal:  Nanoscale Res Lett       Date:  2015-12-10       Impact factor: 4.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.